Marilyn Gordon
Marilyn Gordon
University of Calgary
Verified email at ualberta.ca - Homepage
Title
Cited by
Cited by
Year
RASSF tumor suppressor gene family: biological functions and regulation
N Volodko, M Gordon, M Salla, HA Ghazaleh, S Baksh
FEBS letters 588 (16), 2671-2684, 2014
982014
RASSF1A, Not a Prototypical Ras Effector
M Gordon, S Baksh
Small GTPases, 2011
502011
The tumor suppressor gene, RASSF1A, is essential for protection against inflammation-induced injury
M Gordon, M El-Kalla, Y Zhao, Y Fiteih, J Law, N Volodko, A Mohamed, ...
PloS one 8 (10), e75483, 2013
432013
A simple, cost-effective method for generating murine colonic 3D enteroids and 2D monolayers for studies of primary epithelial cell function
EH Fernando, M Dicay, M Stahl, MH Gordon, A Vegso, C Baggio, L Alston, ...
American Journal of Physiology-Gastrointestinal and Liver Physiology 313 (5 …, 2017
232017
RASSF1 polymorphisms in cancer
M Gordon, M El-Kalla, S Baksh
Molecular biology international 2012, 2012
152012
Increased Intestinal Permeability in Relatives of Patients With Crohn’s Disease Is Not Associated With Small Bowel Ulcerations
CW Teshima, KJ Goodman, M El-Kalla, S Turk, W El-Matary, R Valcheva, ...
Clinical Gastroenterology and Hepatology 15 (9), 1413-1418. e1, 2017
142017
Proteolytic Processing of the Epithelial Adherens Junction Molecule E-Cadherin by Neutrophil Elastase Generates Short Peptides With Novel Wound-Healing Bioactivity
MH Gordon, A Chauvin, FM Boisvert, WK MacNaughton
Cellular and molecular gastroenterology and hepatology 7 (2), 483-486. e8, 2019
52019
220 Asymptomatic First Degree Relatives of Crohn's Patients Display Endoscopic Small Intestinal Lesions Independent of Their Gut Permeability Status
CW Teshima, M El-Kalla, SA Turk, RG Danchak, M Gordon, P Ho, ...
Gastroenterology 142 (5), S-54, 2012
42012
Inhibition of Intestinal Epithelial Wound Healing through Protease-Activated Receptor-2 Activation in Caco2 Cells
EH Fernando, MH Gordon, PL Beck, WK MacNaughton
Journal of Pharmacology and Experimental Therapeutics 367 (2), 382-392, 2018
22018
Inhibition of intestinal epithelial wound healing through protease-activated receptor-2 activation in Caco2 cells
EH Fernando, MH Gordon, PL Beck, WK MacNaughton
Journal of Pharmacology and Experimental Therapeutics 367 (2), 382-392, 2018
22018
N-terminomics/TAILS profiling of proteases and their substrates in ulcerative colitis
MH Gordon, A Anowai, D Young, N Das, RI Campden, H Sekhon, Z Myers, ...
ACS Chemical Biology 14 (11), 2471-2483, 2019
12019
A35 NEUTROPHIL ELASTASE PROTEOLYTIC ACTIVITY DRIVES A NOVEL PRO-RESOLUTION CELL MIGRATION PHENOTYPE
M Gordon, A Dufour, W MacNaughton
Journal of the Canadian Association of Gastroenterology 2 (Supplement_2), 70-71, 2019
2019
A86 NON-PREBIOTIC EFFECTS OF RHAMNOGALACTURONAN ON INTESTINAL EPITHELIAL BARRIER FUNCTION AND WOUND HEALING
CH Baggio, M Gordon, A Nascimento, T Cipriani, W MacNaughton
Journal of the Canadian Association of Gastroenterology 1 (suppl_2), 131-131, 2018
2018
A211 PROTEOLYTIC CLEAVAGE OF E-CADHERIN BY INFLAMMATORY PROTEASES PRODUCES BIOACTIVE PEPTIDES THAT MODIFY EPITHELIAL FUNCTION
M Gordon, W MacNaughton
Journal of the Canadian Association of Gastroenterology 1 (suppl_1), 369-370, 2018
2018
A95 INFLAMMATORY PROTEASES DRIVE A MIGRATORY INTESTINAL EPITHELIAL PHENOTYPE THROUGH THE GENERATION OF BIOACTIVE PEPTIDE FRAGMENTS OF E-CADHERIN
M Gordon, A Chauvin, F Boisvert, W MacNaughton
Journal of the Canadian Association of Gastroenterology 1 (suppl_2), 142-142, 2018
2018
Production of Bioactive Peptides by Neutrophil Elastase Cleavage of E-cadherin
M Gordon, WK MacNaughton
The FASEB Journal 31 (1_supplement), 1042.2-1042.2, 2017
2017
Abstract PR02: Epigenetic and molecular drivers of inflammation-driven colorectal cancer
M Gordon, M Salla, A Said, V Natalia, L Dieleman, S Baksh
Cancer Research 77 (3 Supplement), PR02-PR02, 2017
2017
The Tumor Suppressor RASSF1A Links Inflammation and Cancer
M Gordon
University of Alberta, 2015
2015
The system can't perform the operation now. Try again later.
Articles 1–18